Evidence map›Paper›PMID 29741160›Full record

Trial reportJournal of neural engineering2018

Adaptive deep brain stimulation for Parkinson's disease using motor cortex sensing.

Nicole C Swann, Coralie de Hemptinne, Margaret C Thompson, Svjetlana Miocinovic, Andrew M Miller, Ro'ee Gilron, Jill L Ostrem, Howard J Chizeck, Philip A Starr

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Journal of neural engineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04958096 (Adjunct Cortical Stimulation With Deep Brain Stimulation), which is not on this map. Cited by 206 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
206citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04958096 narecruitingnot on this mapstarted 2021, after this paper: background citation

Adjunct Cortical Stimulation With Deep Brain Stimulation (DBS) to Treat Obsessive Compulsive Disorder (OCD)

TypeinterventionalSponsorAndrew Moses Lee, MD, PhDRan2021 to 2026Enrolled15ConditionsObsessive-Compulsive DisorderArmsStandard Therapeutic Deep Brain Stimulation, Cortical Stimulation for PFC, Cortical Stimulation for ACC
3 · Its place in the literature

Who cites it

206 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Field potential 1/Journal of neurophysiology · 2019
    Trial
  7. The foundational role of autonomy for brain-computer interfaces.Philosophy, ethics, and humanities in medicine : PEHM · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Natural Frequencies of Levodopa-Induced Dyskinesia in Parkinson's Disease.Annals of clinical and translational neurology · 2026
    Article
  12. Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation.Movement disorders : official journal of the Movement Disorder Society · 2026
    Review
  13. Local Field Aperiodic Spectral Power Modulated by Deep Brain Stimulation in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

146 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicole C SwannDepartments of Neurological Surgery, University of California, San Franciso, CA, United States of America.ORCID 0000-0003-2463-5134
Coralie de HemptinneDepartments of Neurological Surgery, University of California, San Franciso, CA, United States of America.
Margaret C ThompsonDepartment of Electrical Engineering, University of Washington, Seattle, WA, United States of America.
Svjetlana MiocinovicDepartment of Neurology, Emory University, Atlanta, GA, United States of America.
Andrew M MillerDepartments of Neurological Surgery, University of California, San Franciso, CA, United States of America.
Ro'ee GilronDepartments of Neurological Surgery, University of California, San Franciso, CA, United States of America.ORCID 0000-0001-8761-5654
Jill L OstremDepartments of Neurology, University of California, San Franciso, CA, United States of America.
Howard J ChizeckDepartment of Electrical Engineering, University of Washington, Seattle, WA, United States of America.
Philip A StarrDepartments of Neurological Surgery, University of California, San Franciso, CA, United States of America.

Funding

Closed Loop Deep Brain Stimulation for Parkinson's DiseaseUH3NS100544 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STARR, PHILIP ANDREW · 2016 to 2022
$4.1M
The motor network in Parkinson's disease: Mechanisms of therapyR01NS090913 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STARR, PHILIP ANDREW · 2014 to 2023
$3.3M
NINDS NIH HHS R01 NS090913NINDS NIH HHS UH3 NS100544
6 · The paper itself

Abstract

objectiveContemporary deep brain stimulation (DBS) for Parkinson's disease is delivered continuously, and adjustments based on patient's changing symptoms must be made manually by a trained clinician. Patients may be subjected to energy intensive settings at times when they are not needed, possibly resulting in stimulation-induced adverse effects, such as dyskinesia. One solution is 'adaptive' DBS, in which stimulation is modified in real time based on neural signals that co-vary with the severity of motor signs or of stimulation-induced adverse effects. Here we show the feasibility of adaptive DBS using a fully implanted neural prosthesis. APPROACH: We demonstrate adaptive deep brain stimulation in two patients with Parkinson's disease using a fully implanted neural prosthesis that is enabled to utilize brain sensing to control stimulation amplitude (Activa PC  +  S). We used a cortical narrowband gamma (60-90 Hz) oscillation related to dyskinesia to decrease stimulation voltage when gamma oscillatory activity is high (indicating dyskinesia) and increase stimulation voltage when it is low. MAIN

resultsWe demonstrate the feasibility of 'adaptive deep brain stimulation' in two patients with Parkinson's disease. In short term in-clinic testing, energy savings were substantial (38%-45%), and therapeutic efficacy was maintained. SIGNIFICANCE: This is the first demonstration of adaptive DBS in Parkinson's disease using a fully implanted device and neural sensing. Our approach is distinct from other strategies utilizing basal ganglia signals for feedback control.

Indexed as

Adaptation, PhysiologicalAgedDeep Brain StimulationHumansMaleMiddle AgedMotor CortexParkinson DiseaseSubthalamic NucleusTreatment Outcome

Identifiers

PMID29741160
PMCPMC6021210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.